Phosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Ferrero, Macarena ^a   Ferragud, Juan ^a   Orlando, Leonardo ^a   Valero, Luz ^a   del Pino, Manuel Sánchez ^a   Farràs, Rosa ^a   de Mora, Jaime Font ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CYCLIN B; CYCLIN DEPENDENT KINASE 1; NOCODAZOLE; PHOSPHATASE; PROTEIN ANTIBODY; SERINE; STEROID RECEPTOR COACTIVATOR 3; CALYCULIN A; CYCLIN A; NCOA3 PROTEIN, HUMAN; OKADAIC ACID; OXAZOLE DERIVATIVE; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL CYCLE M PHASE; CELL FRACTIONATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; NONHUMAN; ONCOGENE; ONCOGENE AIB1; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN COS1; CERCOPITHECUS; CHROMATIN; HELA CELL; METABOLISM; METHODOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; CDC2 PROTEIN KINASE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHROMATIN; COS CELLS; CYCLIN A; CYCLIN B; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; HELA CELLS; HUMANS; MITOSIS; MODELS, BIOLOGICAL; NUCLEAR RECEPTOR COACTIVATOR 3; OKADAIC ACID; OXAZOLES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 82855163977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028602     Document Type: Article

References (33)

1. Avivar A, Garcia-Macias MC, Ascaso E, Herrera G, O'Connor JE, et al. (2006) Moderate overexpression of AIB1 triggers pre-neoplastic changes in mammary epithelium. FEBS Lett 580: 5222-5226.
2. Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, et al. (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6: 263-274.
3. Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT, (2007) Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res 67: 7256-7265.
4. Kajiro M, Hirota R, Nakajima Y, Kawanowa K, So-Ma K, et al. (2009) The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol.
5. Yan J, Erdem H, Li R, Cai Y, Ayala G, et al. (2008) Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 68: 5460-5468.
6. Li S, Shang Y, (2007) Regulation of SRC family coactivators by post-translational modifications. Cell Signal 19: 1101-1112.
7. Ferrero M, Avivar A, Garcia-Macias MC, de Mora JF, (2008) Phosphoinositide 3-kinase/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation. Cancer Res 68: 5450-5459.
8. Planas-Silva MD, Shang Y, Donaher JL, Brown M, Weinberg RA, (2001) AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 61: 3858-3862.
9. Louie MC, Zou JX, Rabinovich A, Chen HW, (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24: 5157-5171.
10. Louie MC, Revenko AS, Zou JX, Yao J, Chen HW, (2006) Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol Cell Biol 26: 3810-3823.
11. Horiguchi K, Arai S, Nishihara T, Nishikawa J, (2006) AIB1 promotes DNA replication by JNK repression and AKT activation during cellular stress. J Biochem 140: 409-419.
12. Hans F, Dimitrov S, (2001) Histone H3 phosphorylation and cell division. Oncogene 20: 3021-3027.
13. Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, et al. (2008) Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455: 119-123.
14. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. Embo J 17: 3052-3065.
15. Macurek L, Lindqvist A, Medema RH, (2009) Aurora-A and hBora join the game of Polo. Cancer Res 69: 4555-4558.
16. Van Horn RD, Chu S, Fan L, Yin T, Du J, et al. (2010) Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells. J Biol Chem 285: 21849-21857.
17. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G, (2008) Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 320: 1655-1658.
18. O'Connell MJ, Krien MJ, Hunter T, (2003) Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell Biol 13: 221-228.
19. Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, et al. (2006) E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 66: 8680-8686.
20. Wu RC, Feng Q, Lonard DM, O'Malley BW, (2007) SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129: 1125-1140.
21. Font de Mora J, Brown M, (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20: 5041-5047.
22. Wu JQ, Guo JY, Tang W, Yang CS, Freel CD, et al. (2009) PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation. Nat Cell Biol 11: 644-651.
23. Kwon YG, Lee SY, Choi Y, Greengard P, Nairn AC, (1997) Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. Proc Natl Acad Sci U S A 94: 2168-2173.
24. Favre B, Turowski P, Hemmings BA, (1997) Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272: 13856-13863.
25. Takeda DY, Wohlschlegel JA, Dutta A, (2001) A bipartite substrate recognition motif for cyclin-dependent kinases. J Biol Chem 276: 1993-1997.
26. Muchardt C, Reyes JC, Bourachot B, Leguoy E, Yaniv M, (1996) The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J 15: 3394-3402.
27. Wu H, Sun L, Zhang Y, Chen Y, Shi B, et al. (2006) Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 281: 21848-21856.
28. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105: 10762-10767.
29. Christova R, Oelgeschlager T, (2002) Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo. Nat Cell Biol 4: 79-82.
30. Li C, Liang YY, Feng XH, Tsai SY, Tsai MJ, et al. (2008) Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol Cell 31: 835-849.
31. Potapova TA, Daum JR, Pittman BD, Hudson JR, Jones TN, et al. (2006) The reversibility of mitotic exit in vertebrate cells. Nature 440: 954-958.
32. Skoufias DA, Indorato RL, Lacroix F, Panopoulos A, Margolis RL, (2007) Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J Cell Biol 179: 671-685.
33. Lu YY, Lam CY, Yung BY, (1996) Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation. Biochem J 317 (Pt 1): 321-327.